Streamline Your B Cell Research from Isolation to Expansion
Due to their essential role in the adaptive immune response, B cells continue to be a focal point for infectious disease, cancer, and autoimmune research. Isolating and generating these cells in relevant numbers continues to be a major challenge in the field. Join this on-demand webinar to learn about reagents for efficient B cell isolation and expansion. This workshop features streamlined culture systems that enable feeder- and serum-free expansion of both human and mouse B cells with high yields, thus providing a complete workflow solution for B cell research.
Contract Assay Services at STEMCELL Technologies Inc
Contract Assay Services is a CRO that specializes in providing primary stem cell-based assays for assessing drug toxicity, efficacy and immunomodulation with hematopoietic, mesenchymal and immune cells
Optimized Workflows for High-Efficiency Genome Editing in Stem and Primary Cell Types
CRISPR-Cas genome editing in cell culture systems is a powerful technique for disease modeling and the development of cellular therapies. Compared to work with immortalized cell lines, genome editing of stem and primary cells presents unique challenges, including issues related to efficient delivery and expression of CRISPR machinery, clonogenicity, and cytotoxicity. In this webinar, our in-house expert, Dr. Ashley Watson, discusses optimized workflows for CRISPR-Cas9 genome editing in human pluripotent stem cells and primary T cells.
ClonaCell™-HY Procedure
Selection and growth of mouse hybridomas to generate mouse monoclonal antibodies using ClonaCell™-HY including preparation of myeloma cells and splenocytes, fusion, selection and cloning, and harvesting